Back to top

Analyst Blog

Arthur J Gallagher & Co. (AJG - Snapshot Report) announced that it has priced an offering of 19 million shares of its common stock at a price of $43.25 per share. Additionally, it also declared that the underwriters may purchase an additional 2.85 million shares of its common stock within a 30-day option.

The offering is expected to close on April 16, 2014, subject to conditions.

Arthur J Gallagher & Co. intends to use the net proceeds from the offering to fund a part of its acquisition of Wesfarmers insurance brokerage operations. The remaining proceeds will be used to repay the borrowings under the company’s line of credit as well as for general corporate purposes, including other acquisitions.

As of 2013, total number of shares outstanding for Arthur J Gallagher & Co. was 135.8 million. With this issuance the share count will rise to approximately 155 million, weighing on the earnings per share of the company.

Arthur J Gallagher reported first-quarter 2014 operating net earnings of 39 cents a share that outperformed the Zacks Consensus Estimate by 52%. The also result increased from the prior-year quarter number by 22%. The Zacks Consensus Estimate for 2014 is currently pegged at $2.41 per share. However, this number may be revised downward as analysts incorporate the new issuance in their model.

Additionally, Arthur J Gallagher & Co. carries a Zacks Rank #3 (Hold) and its Earnings ESP is positive, indicating the stock is likely to deliver a positive earnings surprise in the second quarter of 2014.

Other Stocks to Consider

Some top-ranked stocks worth mentioning in the insurance space include ACE Ltd (ACE - Analyst Report), Erie Indemnity Co. (ERIE - Snapshot Report), Marsh & McLennan Companies, Inc. (MMC - Analyst Report). While ACE Limited sports a Zacks Rank #1 (Strong Buy), Erie Indemnity and Marsh & McLennan both carry a Zacks Rank #2 (Buy).

Read the Full Research Report on AJG
Read the Full Research Report on ACE
Read the Full Research Report on MMC
Read the Full Research Report on ERIE


Zacks Investment Research

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
TRIQUINT SE… TQNT 20.58 +6.24%
RF MICRO DE… RFMD 12.40 +5.53%
VASCO DATA… VDSI 14.83 +5.07%
CHYRONHEGO… CHYR 2.85 +4.78%
PLANAR SYST… PLNR 5.02 +2.87%